Oxford Biomedica Statistics

Total Valuation

LON:OXB has a market cap or net worth of GBP 355.03 million. The enterprise value is 406.58 million.

Market Cap	355.03M
Enterprise Value	406.58M

Important Dates

The last earnings date was Monday, June 23, 2025.

Earnings Date	Jun 23, 2025
Ex-Dividend Date	n/a

Share Statistics

LON:OXB has 106.14 million shares outstanding. The number of shares has increased by 7.15% in one year.

Current Share Class	106.14M
Shares Outstanding	106.14M
Shares Change (YoY)	+7.15%
Shares Change (QoQ)	-3.30%
Owned by Insiders (%)	0.42%
Owned by Institutions (%)	51.33%
Float	55.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.76
PB Ratio	5.87
P/TBV Ratio	12.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.41
EV / Sales	3.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.99

Financial Position

The company has a current ratio of 2.28, with a Debt / Equity ratio of 1.80.

Current Ratio	2.28
Quick Ratio	1.98
Debt / Equity	1.80
Debt / EBITDA	n/a
Debt / FCF	-1.87
Interest Coverage	-3.84

Financial Efficiency

Return on equity (ROE) is -70.28% and return on invested capital (ROIC) is -13.18%.

Return on Equity (ROE)	-70.28%
Return on Assets (ROA)	-9.76%
Return on Invested Capital (ROIC)	-13.18%
Return on Capital Employed (ROCE)	-21.81%
Revenue Per Employee	151,526
Profits Per Employee	-50,812
Employee Count	850
Asset Turnover	0.53
Inventory Turnover	5.73

Taxes

In the past 12 months, LON:OXB has paid 1.34 million in taxes.

Income Tax	1.34M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.52% in the last 52 weeks. The beta is 0.99, so LON:OXB's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	+5.52%
50-Day Moving Average	312.92
200-Day Moving Average	360.23
Relative Strength Index (RSI)	60.97
Average Volume (20 Days)	93,600

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:OXB had revenue of GBP 128.80 million and -43.19 million in losses. Loss per share was -0.42.

Revenue	128.80M
Gross Profit	53.02M
Operating Income	-37.81M
Pretax Income	-47.27M
Net Income	-43.19M
EBITDA	-20.89M
EBIT	-37.81M
Loss Per Share	-0.42

Full Income Statement

Balance Sheet

The company has 60.65 million in cash and 108.76 million in debt, giving a net cash position of -48.11 million or -0.45 per share.

Cash & Cash Equivalents	60.65M
Total Debt	108.76M
Net Cash	-48.11M
Net Cash Per Share	-0.45
Equity (Book Value)	60.49M
Book Value Per Share	0.54
Working Capital	74.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -50.67 million and capital expenditures -7.50 million, giving a free cash flow of -58.16 million.

Operating Cash Flow	-50.67M
Capital Expenditures	-7.50M
Free Cash Flow	-58.16M
FCF Per Share	-0.55

Full Cash Flow Statement

Margins

Gross margin is 41.17%, with operating and profit margins of -29.35% and -33.53%.

Gross Margin	41.17%
Operating Margin	-29.35%
Pretax Margin	-36.70%
Profit Margin	-33.53%
EBITDA Margin	-16.22%
EBIT Margin	-29.35%
FCF Margin	n/a

Dividends & Yields

LON:OXB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.15%
Shareholder Yield	n/a
Earnings Yield	-12.17%
FCF Yield	-16.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 30, 2018. It was a reverse split with a ratio of 0.02.

Last Split Date	May 30, 2018
Split Type	Reverse
Split Ratio	0.02

Scores

LON:OXB has an Altman Z-Score of -0.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.89
Piotroski F-Score	1